Abstract
QPX7728 is a new ultrabroad-spectrum inhibitor of serine and metallo-beta-lactamases (MBLs) from a class of cyclic boronates that gave rise to vaborbactam. The spectrum and mechanism of beta-lactamase inhibition by QPX7728 were assessed using purified enzymes from all molecular classes. QPX7728 inhibits class A extended-spectrum beta-lactamases (ESBLs) (50% inhibitory concentration [IC50] range, 1 to 3 nM) and carbapenemases such as KPC (IC50, 2.9 ± 0.4 nM) as well as class C P99 (IC50 of 22 ± 8 nM) with a potency that is comparable to or higher than recently FDA-approved beta-lactamase inhibitors (BLIs) avibactam, relebactam, and vaborbactam. Unlike those other BLIs, QPX7728 is also a potent inhibitor of class D carbapenemases such as OXA-48 from Enterobacteriaceae and OXA enzymes from Acinetobacter baumannii (OXA-23/24/58, IC50 range, 1 to 2 nM) as well as MBLs such as NDM-1 (IC50, 55 ± 25 nM), VIM-1 (IC50, 14 ± 4 nM), and IMP-1 (IC50, 610 ± 70 nM). Inhibition of serine enzymes by QPX7728 is associated with progressive inactivation with a high-efficiency k 2/K ranging from 6.3 × 104 (for P99) to 9.9 × 105 M-1 s-1 (for OXA-23). This inhibition is reversible with variable stability of the QPX7728-beta-lactamase complexes with t...Continue Reading
References
Jul 15, 1987·Biochemical Pharmacology·F De MeesterS G Waley
May 16, 1980·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R P Ambler
Sep 1, 1982·The Biochemical Journal·S G Waley
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·M GalleniUNKNOWN Metallo-beta-lactamases Working Group
May 30, 2009·Chemistry & Biology·Jean-Denis DocquierStefano Mangani
Dec 17, 2009·Antimicrobial Agents and Chemotherapy·Krisztina M Papp-WallaceRobert A Bonomo
Jan 13, 2010·Clinical Microbiology Reviews·Sarah M Drawz, Robert A Bonomo
Oct 6, 2010·Current Opinion in Microbiology·Karen Bush
Jul 4, 2012·Proceedings of the National Academy of Sciences of the United States of America·David E EhmannStewart L Fisher
Aug 6, 2013·The Journal of Biological Chemistry·David E EhmannStewart L Fisher
Jan 18, 2014·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
Nov 20, 2014·ACS Chemical Biology·Sushmita D LahiriJean-Denis Docquier
Mar 18, 2015·Journal of Medicinal Chemistry·Scott J HeckerMichael N Dudley
Jan 6, 2016·Antimicrobial Agents and Chemotherapy·Laura J RojasRobert A Bonomo
Jun 23, 2016·Cold Spring Harbor Perspectives in Medicine·Karen Bush, Patricia A Bradford
Oct 16, 2016·Cold Spring Harbor Perspectives in Medicine·Robert A Bonomo
Jul 1, 2017·Nature Microbiology·Thomas F Durand-RévilleAlita A Miller
Aug 25, 2017·ACS Infectious Diseases·Adam B ShapiroAlita A Miller
Aug 30, 2017·Antimicrobial Agents and Chemotherapy·Olga LomovskayaMichael N Dudley
Apr 4, 2018·Antimicrobial Agents and Chemotherapy·Krisztina M Papp-WallaceRobert A Bonomo
Aug 1, 2018·Antimicrobial Agents and Chemotherapy·Karen Bush
Mar 7, 2019·Nature Reviews. Microbiology·Karen Bush, Patricia A Bradford
Mar 14, 2019·MBio·Melissa D BarnesRobert A Bonomo
Aug 28, 2019·Journal of Medicinal Chemistry·Alen KrajncChristopher J Schofield
Sep 11, 2019·Expert Opinion on Pharmacotherapy·Krisztina M Papp-Wallace
Nov 13, 2019·Antimicrobial Agents and Chemotherapy·Ruslan Tsivkovski, Olga Lomovskaya
Nov 26, 2019·Journal of Medicinal Chemistry·Bin LiuChristopher J Burns
Dec 11, 2019·PloS One·Ian A CritchleyRodrigo Mendes
Dec 25, 2019·Antimicrobial Agents and Chemotherapy·Jodie C HamrickDenis M Daigle
Mar 10, 2020·Journal of Medicinal Chemistry·Scott J HeckerMichael N Dudley
Citations
Apr 2, 2020·Antimicrobial Agents and Chemotherapy·Olga LomovskayaMichael N Dudley
Apr 2, 2020·Antimicrobial Agents and Chemotherapy·Olga LomovskayaMichael N Dudley
Jun 7, 2020·Biomolecules·Antonella R PalaciosAlejandro J Vila
Jun 3, 2020·Antimicrobial Agents and Chemotherapy·Kirk NelsonOlga Lomovskaya
Jul 22, 2020·Antimicrobial Agents and Chemotherapy·Sara E BoydWilliam W Hope
Mar 28, 2020·International Journal of Environmental Research and Public Health·Yanling WangJianfeng Wang
May 1, 2020·Biomolecules·Scott T LefurgyRobert A Bonomo
Sep 2, 2020·Antimicrobial Agents and Chemotherapy·Kirk NelsonOlga Lomovskaya
Jun 20, 2020·Expert Opinion on Pharmacotherapy·Martina SpazianteMario Venditti
Dec 4, 2020·Infection and Drug Resistance·Toni A Campanella, Jason C Gallagher
Nov 6, 2020·The Journal of Antimicrobial Chemotherapy·Shazad MushtaqDavid M Livermore
Dec 8, 2020·Biochemistry. Biokhimii︠a︡·A M EgorovM Yu Rubtsova
Dec 10, 2020·International Journal of Molecular Sciences·Juan C Vázquez-UchaAlejandro Beceiro
Mar 7, 2021·Antibiotics·Cristina Lasarte-MonterrubioAlejandro Beceiro
Mar 24, 2021·Antimicrobial Agents and Chemotherapy·Viivi H A HirvonenMarc W van der Kamp
Mar 31, 2021·Antimicrobial Agents and Chemotherapy·Olga LomovskayaMichael Dudley
May 26, 2021·Expert Review of Anti-infective Therapy·Ilias KaraiskosHelen Giamarellou
Jun 16, 2021·Chemical Reviews·Guillermo BahrAlejandro J Vila
Jul 12, 2021·The Lancet Infectious Diseases·Maria F MojicaRobert A Bonomo
Jun 21, 2021·Chemical Biology & Drug Design·Woo Shik ShinYuk Yin Sham
Jul 25, 2021·The Journal of Antimicrobial Chemotherapy·Dee ShortridgeMariana Castanheira
Aug 7, 2021·ACS Infectious Diseases·Philip HinchliffeJames Spencer
Aug 15, 2021·European Journal of Medicinal Chemistry·Kalyan C Nagulapalli VenkataSiddharth K Tripathi
Dec 12, 2020·Journal of Medicinal Chemistry·David T DaviesMartin Everett
Aug 28, 2021·Antibiotics·Carola MauriLuigi Principe
Mar 10, 2020·Journal of Medicinal Chemistry·Scott J HeckerMichael N Dudley
Aug 24, 2021·Frontiers in Microbiology·Emilio Lence, Concepción González-Bello